# FDA recall D-017-2013

> **Watson Laboratories Inc** · Class II · drug recall initiated 2012-10-19.

## Product

Necon 1/35-28 (norethindrone and ethinyl estradiol) Tablets USP, 1 mg/35 mcg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Pharma, Inc., A subsidiary of Watson Pharmaceuticals, Inc., Corona, CA  92880 USA; NDC 52544-552-28.

## Reason for recall

Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).

## Distribution

Nationwide and Puerto Rico

## Key facts

- **Recall number:** D-017-2013
- **Recalling firm:** Watson Laboratories Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-10-19
- **Report date:** 2012-10-31
- **Termination date:** 2013-11-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Corona, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-017-2013

## Citation

> AI Analytics. FDA recall D-017-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-017-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*